We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.61%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22B
AUM Growth
-$123M
(-0.55%)
Cap. Flow
-$1.19B
Cap. Flow
% of AUM
-5.42%
Top 10 Holdings %
Top 10 Hldgs %
11.79%
Holding
1,359
New
101
Increased
421
Reduced
517
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$62M |
| 2 |
UBS Group
UBS
|
+$49.7M |
| 3 |
Air Products & Chemicals
APD
|
+$47.3M |
| 4 |
AT&T
T
|
+$44.6M |
| 5 |
Lam Research
LRCX
|
+$39.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hewlett Packard
HPE
|
+$61.6M |
| 2 |
HCA Healthcare
HCA
|
+$50.8M |
| 3 |
Gen Digital
GEN
|
+$50.7M |
| 4 |
Baxter International
BAX
|
+$50.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$49.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.71% |
| 2 | Healthcare | 16.86% |
| 3 | Financials | 11.57% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOLX
301
DELISTED
Hologic
HOLX
| $16.4M | 0.07% |
360,409
-1,750
| -0.5% | -$77.2K |
|
302
Lear
LEA
$6.28B
| $16.3M | 0.07% |
114,419
+5,500
| +5% | +$779K |
|
303
Cirrus Logic
CRUS
$6.24B
| $16.2M | 0.07% |
258,723
-110,197
| -30% | -$7.13M |
|
|
BCR
304
DELISTED
CR Bard Inc.
BCR
| $16.1M | 0.07% |
51,019
-10,796
| -17% | -$3.21M |
|
|
SCHW
305
Charles Schwab
SCHW
$187B
| $16.1M | 0.07% |
373,972
+10,317
| +3% | +$413K |
|
306
Iron Mountain
IRM
$33.5B
| $16M | 0.07% |
465,385
+332,544
| +250% | +$11.6M |
|
307
Deere & Co
DE
$185B
| $15.9M | 0.07% |
129,031
-14,500
| -10% | -$1.7M |
|
308
Occidental Petroleum
OXY
$63.6B
| $15.9M | 0.07% |
266,267
-20,779
| -7% | -$1.27M |
|
309
Intercontinental Exchange
ICE
$87.8B
| $15.8M | 0.07% |
239,655
+93,300
| +64% | +$5.72M |
|
310
Republic Services
RSG
$69.1B
| $15.7M | 0.07% |
246,340
-78,500
| -24% | -$4.97M |
|
311
Magna International
MGA
$17B
| $15.7M | 0.07% |
338,192
+54,857
| +19% | +$2.38M |
|
312
Caterpillar
CAT
$360B
| $15.6M | 0.07% |
145,130
-13,141
| -8% | -$1.33M |
|
|
PKY
313
DELISTED
Parkway, Inc.
PKY
| $15.5M | 0.07% |
678,396
+493,900
| +268% | +$9.95M |
|
|
RHT
314
DELISTED
Red Hat Inc
RHT
| $15.5M | 0.07% |
161,600
+30,600
| +23% | +$2.73M |
|
315
Freeport-McMoran
FCX
$99.2B
| $15.4M | 0.07% |
+1,283,442
| New | +$15.6M |
|
316
ConocoPhillips
COP
$169B
| $15.3M | 0.07% |
347,181
-919,998
| -73% | -$42.9M |
|
317
Cummins
CMI
$74B
| $15.1M | 0.07% |
93,000
-122,700
| -57% | -$19M |
|
|
OXFD
318
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $15M | 0.07% |
894,388
-23,080
| -3% | -$345K |
|
319
Jazz Pharmaceuticals
JAZZ
$15.6B
| $14.8M | 0.07% |
94,855
+63,155
| +199% | +$9.66M |
|
320
News Corp Class A
NWSA
$16.3B
| $14.7M | 0.07% |
1,073,950
+260,500
| +32% | +$3.41M |
|
321
Ultragenyx Pharmaceutical
RARE
$1.29B
| $14.7M | 0.07% |
236,653
+70,968
| +43% | +$4.28M |
|
322
American Electric Power
AEP
$65.8B
| $14.4M | 0.07% |
207,457
+105,000
| +102% | +$7.29M |
|
323
Equifax
EFX
$19.8B
| $14.3M | 0.07% |
104,426
-2,100
| -2% | -$288K |
|
324
Deluxe
DLX
$1.08B
| $14.3M | 0.06% |
206,617
-41,482
| -17% | -$2.89M |
|
325
Palo Alto Networks
PANW
$309B
| $14.3M | 0.06% |
640,122
+63,024
| +11% | +$1.27M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2017 Portfolio in Review
As of Q2 2017, Axa held 1,359 positions worth $22B, down 0.55% from $22.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Axa withdrew a net $1.19B in Q2 2017, closing 125 positions and reducing 517 holdings. Its most notable exit was Mead Johnson Nutrition Company, an estimated $22.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Element Solutions worth $22.3M.
- Axa's largest Q2 2017 buy was Element Solutions: 1,758,931 shares worth $22.3M.
- Axa added most to Micron Technology in Q2 2017, an estimated $62M increase.
- Axa's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $61.6M.
- Axa fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $22.7M.
- Axa's ten largest holdings make up 12% of its $22B portfolio in Q2 2017.
- Axa opened 101 new positions and closed 125 in Q2 2017.
- Axa's portfolio value fell 0.55% quarter-over-quarter to $22B.
Based on Axa's 13F filing for Q2 2017, filed 10 Aug 2017.